Multiple Sclerosis Drugs Market Size is projected to reach USD 34.03 Billion by 2031, growing at a CAGR of 3.7%: Straits Research New York, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Multiple sclerosis (MS) is an immune-mediated central nervous system disorder. Demyelination, inflammation, degenerative changes such as...

Octave Bioscience Secures $14 Million Series A Financing Round MENLO PARK, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Octave Bioscience, the developer of a fully integrated care management solution delivering powerful insights for patients with neurodegenerative...